1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Three models combining an imaging parameter with clinical factors as potential prognostic variables of overall survival in patients with gliomas
Factors HR (95% CI) P Value Model 1 Age older than 50 yr 1.03 (0.99–1.06) .17 Biopsy vs resection 4.11 (1.68–10.05) .002 Grade 3 vs 2 1.20 (0.19–7.65) .85 Grade 4 vs 2 1.21 (0.28–5.33) .80 Karnofsky score < 80 2.56 (1.19–5.51) .02 Ktrans ≥ 0.05 min−1 4.53 (1.22–16.82) .02 Model 2 Age older than 50 yr 1.06 (1.03–1.09) .0002 Biopsy vs resection 3.68 (1.54–8.78) .004 Grade 3 vs 2 1.06 (0.16–6.89) .95 Grade 4 vs 2 1.76 (0.35–8.75) .49 Karnofsky score < 80 3.21 (1.48–6.92) .003 Vp ≥ 5 mL/100 g 1.30 (0.37–4.54) .68 Model 3 Age older than 50 yr 1.03 (0.99–1.07) .087 Biopsy vs resection 4.36 (1.77–10.77) .002 Grade 3 vs 2 1.28 (0.20–8.25) .79 Grade 4 vs 2 1.00 (0.22–4.63) .99 Karnofsky score < 80 2.51 (1.16–5.43) .02 Marked contrast enhancement 4.79 (1.22–18.87) .03